New York State's Biodefense Laboratory

Research

State-of-the-art diagnostic testing capabilities rely on the latest research findings and access to the latest technologies. This allows for the rapid application of novel concepts or emerging technologies to public health threats. Research conducted in the Biodefense Laboratory fosters collaboration with other scientists at Wadsworth and from institutions conducting related investigations.

|

• Rapid prototyping of diagnostic assays (e.g., monkeypox, ricin toxin) to support service gaps.
• Maturation of technologies to reduce cost or improve performance (e.g., multiplex real-time PCR (image) and fluorescent microsphere arrays).
• Development of novel diagnostic screening assays to supplant more hazardous diagnostic assays (e.g., botulinum toxin real-time PCR versus a gold-standard mouse bioassay).
• Publications of research findings and assay development